These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24637737)

  • 1. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
    Lo YL; Liu Y
    PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells.
    Lo YL; Tu WC
    Chem Biol Interact; 2015 Dec; 242():13-23. PubMed ID: 26335193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
    Lee YK; Lin TH; Chang CF; Lo YL
    PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
    Lo YL; Wang W
    Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.
    Juang V; Lee HP; Lin AM; Lo YL
    Int J Nanomedicine; 2016; 11():6047-6064. PubMed ID: 27895479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.
    Lo YL
    Int J Mol Sci; 2012 Dec; 14(1):158-76. PubMed ID: 23344026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.
    Pakunlu RI; Wang Y; Tsao W; Pozharov V; Cook TJ; Minko T
    Cancer Res; 2004 Sep; 64(17):6214-24. PubMed ID: 15342407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.
    Pakunlu RI; Cook TJ; Minko T
    Pharm Res; 2003 Mar; 20(3):351-9. PubMed ID: 12669953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
    Lo YL; Lee HP; Tu WC
    Int J Mol Sci; 2015 Sep; 16(9):22711-34. PubMed ID: 26393585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
    Lo YL; Ho CT; Tsai FL
    Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
    Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7,3',4'-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species.
    Lo YL; Wang W; Ho CT
    Toxicology; 2012 Dec; 302(2-3):221-32. PubMed ID: 22914566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
    Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis.
    Cai B; Miao Y; Liu Y; Xu X; Guan S; Wu J; Liu Y
    PLoS One; 2013; 8(8):e69611. PubMed ID: 24013781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
    Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
    Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.
    Pakunlu RI; Wang Y; Saad M; Khandare JJ; Starovoytov V; Minko T
    J Control Release; 2006 Aug; 114(2):153-62. PubMed ID: 16889867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
    Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
    Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.